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BACKGROUND: Studies assessing the relationships of anthropometry and testicular germ-cell tumour (TGCT) have reported
heterogeneous findings.
METHODS: We undertook a systematic review and meta-analysis of the associations between adult height, weight, body mass index
(BMI), and testicular cancer. Search strategies were conducted in PubMed, EMBASE, Scopus, and Web of Science on 26 May 2009.
Studies that met our inclusion criteria were included in meta-analytic models using STATA 11.
RESULTS: A total of 3255 references were retrieved, of which 14 met the inclusion criteria. Random effects meta-analysis found adult
height (odds ratio (OR) per 5-cm increase 1.13, 95% confidence interval (CI) 1.07–1.19, Po0.001) and weight (OR overweight vs
normal 0.92, 95% CI 0.86–0.98, P¼0.011) to be associated with TGCT. The meta-analysis of weight and TGCT produced a
summary estimate, which indicated no association, although an analysis restricted studies to North American was suggestive of
association (OR per 1-kg increase 1.01, 95% CI 1.00–1.01, Po0.001).
CONCLUSIONS: This systematic review and meta-analysis has found evidence for a positive association of adult height and TGCT, and
tentative evidence for an inverse association of BMI and TGCT.
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Testicular cancer is a relatively rare malignancy in the general
population, but is the most commonly occurring cancer among
young men in many countries (Bjorge et al, 2006; Bray et al, 2006;
Shah et al, 2007). Established risk factors for testicular cancer
include European ancestry (Newell et al, 1987), cryptorchidism
(Garner et al, 2005), family history of testicular cancer,
and previous diagnosis of testicular cancer (McGlynn, 2001). In
addition, meta-analytic synthesis of all available pre- and perinatal
data has implicated low-birth order, maternal bleeding during
pregnancy, larger sibship size, low-birth weight, twinning, gesta-
tional age, and inguinal hernia in the etiopathogenesis of testicular
cancer (Cook et al, 2009, 2010). There is also an increasing amount
of evidence that height and potentially overall body size, variables
which are largely determined during early development, may also
be related to risk, although the literature is not entirely consistent
(Dieckmann et al, 2009).
Adult height is determined in early life by a combination of
genetics, health and nutrition (Albanes et al, 1988). There is some
evidence that high fat or high dairy intake in childhood is
associated with both adult body size and risk for testicular cancer
(Davies et al, 1996; Stang et al, 2006; McGlynn et al, 2007; Lagorio
et al, 2008). Growth factors and growth factor binding proteins
have also been examined as possible risk factors for testicular
cancer (Chia et al, 2008). Although it is unlikely that height, weight
or body mass index (BMI) are direct determinants of testicular
cancer risk, it is probable that some underlying factor influences
both body size and risk of testicular cancer. To clarify these
relationships and to investigate inconsistencies in the literature, we
undertook a systematic review and meta-analysis of adult height,
weight, and BMI in relation to the risk of testicular cancer.
MATERIALS AND METHODS
With assistance from the National Institutes of Health Library, a
comprehensive search strategy was designed to incorporate all
possible terms and keywords relating to testicular cancer and
body size. A search of the literature was executed on 26 May
2009 using four major scientific literature databases, PubMed
(National Centre for Biotechnology Information, US National
Library of Medicine, USA; 1900–2009), EMBASE (Elsevier BV,
The Netherlands; 1974–2009), Scopus (Elsevier BV, The Netherlands;
1823–2009), and Web of Science (Thomson Reuters, USA;
1900–2009). Search strategies are available from the authors on
request. Titles, abstracts, and keywords were assessed by two
reviewers (CCL and MBC). Articles were compiled and managed
using Endnote X3 software (Thomson Reuters, 2009).
To be included in the meta-analysis, studies had to meet the
following criteria; (1) have at least 20 cases and 20 controls in the
analysis; (2) recruited only incident cases to avoid survivor-
ship bias; and (3) have a valid control group (no case-series or
case-study designs were included). For the meta-analysis of adult
weight, it was required to have the weight ascertained shortly
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adult height, it was required to have the height ascertained at age
18 years or older. Both of these conditions had to be met for a
study to be eligible for the meta-analysis of BMI. No restrictions
were placed on year or language of publication. If a single study
had reported results in more than one publication, that with the
largest number of cases was included.
Variables abstracted from studies included country of study
population, institute or hospital, years of study, study design,
patient selection criteria and source, mean age of study
participants, mean age at diagnosis, race/ethnicity, data ascertain-
ment method, and whether the study included all testicular
tumours or only testicular germ cell tumours (TGST) (the most
common type of testicular tumours).
Statistical analyses
All analyses were performed in STATA v.11 (StataCorp, 2009).
Meta-analyses of the relevant continuous variables (height, weight,
BMI) were performed to estimate odds of testicular cancer per unit
increase, according to methods previously outlined by Chene and
Thompson (1996). BMI (kgm
 2) was also examined as an ordinal
variable using groupings of normal (BMI o25), overweight (BMI
25–29.9), and obese (BMI X30). A random-effects meta-analysis
was used according to the methods of DerSimonian and Laird
(1986). The I
2 value and its 95% uncertainty intervals (UIs) were
used to assess the consistency of the study-specific estimates
(Higgins et al, 2003). A funnel plot of the log odds ratio (OR)
against the s.e. of the log OR was examined as an indicator of
publication bias. Egger and Begg’s tests were performed to test for
small-study effects (Begg and Mazumdar, 1994; Egger et al, 1997).
A sensitivity analysis was conducted whereby each study was
omitted in turn and the summary estimate recalculated to
determine the influence of each study.
Meta-regression was performed for each of the body-size
variables under consideration to investigate heterogeneity (Higgins
and Thompson, 2004). Variables for meta-regression were
designated a priori and included year of study, country, study
design, ascertainment method, institute or hospital, time of study,
time of follow-up, and whether the study included all testicular
tumours or only germ cell tumours. The results of a meta-
regression are only reported and discussed if the P-value was less
than the arbitrary value of 0.05.
RESULTS
From our comprehensive and sensitive search strategy we collated
3255 articles of potential interest. Two authors (CL and MBC)
reviewed titles and abstracts of these articles and identified 189
articles of potential interest (101 original research articles and 88
review articles). The full-text of each article was retrieved and the
manuscript was considered against the stipulated selection criteria
for our review. Four additional original research articles were
identified through review of citations of the full-text articles, for a
total of 195 relevant articles. Any discrepancies regarding inclusion
were discussed among all the three authors until consensus was
reached. In total, 21 authors were contacted and requested for
further information, of whom 19 replied and 8 provided additional
information or unpublished data. In total, 14 articles met the
selection criteria, provided the appropriate information or data to
calculate OR, and were able to be included in at least two of the
three (height, weight, and BMI) meta-analyses (Table 1). We did
not exclude articles based on type of testicular cancer (germ cell
tumours or all tumours), but all the articles matching our inclusion
criteria studied only TGCT.
Adult height and weight were used to calculate BMI of
individuals of each study. Included studies used weight at TGCT
diagnosis (Petridou et al, 1997; Hardell et al, 2006; Dieckmann
et al, 2009) or weight approximately 1 year before diagnosis
(Davies et al, 1990; UKTCSG, 1994; Walcott et al, 2002; Stang et al,
2006; McGlynn et al, 2007), 2 or more years before diagnosis
(Richiardi et al, 2003; Pan et al, 2004), at age 20 (Swerdlow et al,
1989; Dieckmann and Pichlmeier, 2002), at age 21 (Gallagher
et al, 1995), or at some unspecified time before diagnosis (Bjorge
et al, 2006).
In the meta-analysis of the association between adult height and
TGCT, 13 studies were included which, in combination, produced
a summary OR of 1.13 per 5cm increase in height (95% CI: 1.07–
1.19, Po0.001; Figure 1). The heterogeneity between studies, as
measured by the I
2 value, was 77% (95% UI 60–86%). The high
heterogeneity was not explained by meta-regression of those
variables specified a priori. The Egger and Begg’s tests both
indicated no small-study effects (P¼0.819 and P¼0.714, respec-
tively). A total of 12 studies contributed to the analysis of the
association between adult weight and TGCT (Figure 2). Findings
indicated that adult weight was unrelated to TGCT, with a
summary risk estimate of 1.00 per 1kg increase in weight (95%
CI: 1.00–1.01, P¼0.508). The I
2 value measuring between-study
heterogeneity was 60% (95% UI: 24–79%). Egger and Begg’s tests
found no evidence for any small-study effects (P¼0.480 and
P¼0.337, respectively).
Meta-regression of adult weight by continent (North America
against Europe) was of borderline statistical significance
(P¼0.058). A stratified forest plot graphically illustrates the
differences in the relationship between adult weight and TGCT by
continent (Figure 3). The European studies had a summary risk
estimate of 1.00 per 1kg increase in weight (95% CI: 0.99–1.01,
P¼0.643) with an I
2 value for between-study heterogeneity of 58%,
whereas North-American studies produced a borderline statisti-
cally significant summary estimate of 1.01 per 1kg increase in
weight (95% CI: 1.00–1.01, P¼0.001) with an I
2 value of 0%. Meta-
regressions of study design, country of study population, and data
ascertainment method were all null.
BMI was analysed both as a continuous and as a categorical
metric in relation to TGCT. Thirteen studies were included in the
continuous meta-analysis in which we found a tentative inverse
relationship with TGCT with a summary risk estimate of 0.99 per
one unit increase in BMI (95% CI: 0.97–1.00, P¼0.053; Figure 4).
The I
2 value was the lowest of all I
2 values calculated for the
continuous analyses at 45% (95% UI: 0–71%) indicating a
moderate amount of between-study heterogeneity. The Egger and
Begg’s tests did not provide strong evidence for small-study effects
(P¼0.081 and P¼0.393, respectively).
In total, 11 studies contributed to the categorical meta-analysis
of BMI (kgm
 2) and TGCT (Figure 5). For the categorical analyses,
normal weight men (BMI o25) were used as the referent for
comparison with overweight men (BMI 25–29.9), and obese men
(BMI X30). We found that overweight was inversely related to
TGCT, compared with normal weight, with a summary OR of 0.92
per unit BMI (95% CI: 0.86–0.98, P¼0.011) with no heterogeneity
indicated (I
2¼0%). Sensitivity analysis demonstrated that the
study by Dieckmann et al (2009) was particularly influential
because of its large size, and thus high weighting in the BMI
analysis. Moreover, its null finding is in contrast with that of most
other studies. When this study was excluded from the meta-
analysis, the summary estimate indicated an even stronger inverse
relationship (OR¼0.87 per unit BMI, 95% CI: 0.80–0.95, I
2¼7%).
When we compared the obese group with the referent group, BMI
was not related to TGCT, with a summary risk estimate of 0.92 per
unit BMI (95% CI: 0.75–1.15, P¼0.496) with an I
2 of 46% (95%
UI: 0–100%). Again, sensitivity analysis showed that the study by
Dieckmann et al (2009) was highly influential and when this
study was omitted, the obesity-TGCT meta-analysis indicated
an association of borderline statistical significance (OR¼0.85
per unit BMI, 95% CI: 0.71–1.01, P¼0.068). The heterogeneity
Meta-analysis of body size and TGCT
CC Lerro et al
1468
British Journal of Cancer (2010) 103(9), 1467–1474 & 2010 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
ywas lower after the omission of the Dieckmann et al (2009)
study, but the uncertainty interval was just as large (I
2¼7%, 95%
UI: 0–100%).
Variables assessed using meta-regression included country of
study population (grouped by continent), study design, and data
ascertainment method. Meta-regression of variables such as mean
age at diagnosis and mean age of study participants could not be
conducted because they were not available for all included studies.
DISCUSSION
In this systematic review and meta-analysis of body size in relation
to TGCT, we found a positive association with height and an
inverse association with BMI. The meta-analysis of weight and
TGCT indicated no association. The association between height
and testicular cancer has been examined by 17 studies, 13 of which
were included in this meta-analysis. Although there was evidence
of a moderate-to-high amount of heterogeneity among the
13 studies included, all but three reported a positive association
(Swerdlow et al, 1989; Petridou et al, 1997; Hardell et al, 2006). Of
the four studies (Brown et al, 1987; Thune and Lund, 1994; Davies
et al, 1996; Rasmussen et al, 2003) that were not included in the
meta-analysis because of missing or incomplete data, one (Davies
et al, 1996) found a non-significant inverse association, whereas
three (Brown et al, 1987; Thune and Lund, 1994; Rasmussen et al,
2003) found positive associations, although only one of these latter
estimates was statistically significant at the 0.05 level (Rasmussen
et al, 2003).
Both height and TGCT incidence follow a birth-cohort effect
(Bergstrom et al, 1996; Cole, 2000; McGlynn et al, 2003) and are
thought to be influenced by a combination of genetic (Biermann
et al, 2007), perinatal (Ekbom, 1998), and early childhood factors
(Meyer and Selmer, 1999; Bjorge et al, 2006). There is some
evidence to suggest that testicular cancer is associated with
increased consumption of calories (Sigurdson et al, 1999), fat
(Armstrong and Doll, 1975; Paulozzi, 1998; Sigurdson et al, 1999),
and dairy products (1971; Armstrong and Doll, 1975; Davies et al,
1996; Ganmaa et al, 2002; Stang et al, 2006) during the
developmental period, although the literature is not entirely
consistent (Bonner et al, 2002; Walcott et al, 2002; McGlynn
et al, 2007), which is likely the result of the low sensitivity and
Table 1 Studies included in the meta-analytic models
Title
First
author Year Country
Number
of
cases
Study
design
Ascertain-
ment
method
Risk
estimate:
height
Risk
estimate:
weight
Risk
estimate:
BMI
Testis cancer: post-natal
hormonal factors, sexual behaviour
and fertility (Swerdlow et al, 1989)
Swerdlow 1989 UK 259 Case-control Self-report 0.96 (0.85, 1.07) — 1.02 (0.96, 1.08)
Body size and cancer of the testis
(Davies et al, 1990)
Davies 1990 Denmark 438 Case-control Record/registry 1.01 (0.93, 1.10) 0.99 (0.98, 1.00) 0.96 (0.91, 1.01)
Social, behavioural and medical
actors in the aetiology of testicular
cancer: results from the UK study
(UKTCSG, 1994)
UKTCSG 1994 UK 794 Case-control Self-report 1.05 (0.97, 1.14) 1.00 (0.99, 1.01) 1.00 (0.97, 1.03)
Physical-activity, medical history, and
risk of testicular cancer (Alberta
and British-Columbia, Canada)
(Gallagher et al, 1995)
Gallagher 1995 Canada 510 Case-control Self-report 1.20 (1.09, 1.33) 1.01 (1.00, 1.02) 1.00 (0.97, 1.03)
Baldness and other correlates of
sex hormones in relation to
testicular cancer (Petridou et al,
1997)
Petridou 1997 Greece 97 Case-control Self-report 0.98 (0.82, 1.18) 0.97 (0.95, 0.99) 0.90 (0.83, 0.98)
Is risk of testicular cancer related
to body size? (Dieckmann and
Pichlmeier, 2002)
Dieckmann 2002 Germany 353 Case-control Self-Report 1.35 (1.20, 1.52) 1.02 (0.99, 1.04) 0.99 (0.92, 1.05)
A case-control study of dietary
phytoestrogens and testicular
cancer risk (Walcott et al, 2002)
Walcott 2002 US 159 Case-control Self-report 1.15 (0.98, 1.35) 1.00 (0.98, 1.01) 0.97 (0.91, 1.04)
Body size at birth and adulthood
and the risk for germ-cell testicular
cancer (Richiardi et al, 2003)
Richiardi 2003 Sweden 371 Case-control Record/registry 1.17 (1.05, 1.30) 1.01 (0.99, 1.03) 0.94 (0.85, 1.05)
Association of obesity and cancer
risk in Canada (Pan et al, 2004)
Pan 2004 Canada 685 Case-control Self-report 1.26 (1.19, 1.34) 1.01 (1.00, 1.02) 0.97 (0.95, 1.00)
In utero exposure to persistent
organic pollutants in relation to
testicualr cancer risk (Hardell
et al, 2006)
Hardell 2006 Sweden 58 Case-control Self-report 0.96 (0.68, 1.36) 0.97 (0.94, 1.00) 0.96 (0.84, 1.09)
The impact of height and body
mass index on the risk of testicular
cancer in 600000 Norwegian
men (Bjorge et al, 2006)
Bjorge 2006 Norway 1004 Cohort Record/registry 1.08 (1.03, 1.13) 1.00 (0.99, 1.01) 0.97 (0.95, 0.99)
Adolescent milk fat and galactose
consumption and testicular germ
cell cancer (Stang et al, 2006)
Stang 2006 Germany 269 Case-control Self-report 1.23 (1.11, 1.37) 1.01 (0.99, 1.02) —
Body size, dairy consumption,
puberty, and risk of testicular
germ cell tumors (McGlynn et al,
2007)
McGlynn 2007 US 767 Case-control Self-report 1.16 (1.08, 1.25) 1.01 (1.00, 1.02) 0.99 (0.95, 1.04)
Is increased body mass index
associated with the incidence of
testicular germ cell cancer?
(Dieckmann et al, 2009)
Dieckmann 2009 Germany 8498 Case-control Self-report — — 1.01 (1.00, 1.03)
Abbreviations: BMI¼body mass index; UK¼United Kingdom; US¼United States.
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exposure over a long time period. However, these consumption
hypotheses could conceivably be explained by the birth-cohort
effects, including the declined incidence of testicular cancer
observed in certain western European countries during the Second
World War (Moller, 1989), and the subsequent increased incidence
thereafter (Chia et al, 2010). Alternatively, height could be a proxy
for testis size, given evidence that these anthropometric features
are correlated (Handelsman and Staraj, 1985; Sobowale and
Akiwumi, 1989), and an increased testis size may relate to an
increased testicular cancer risk. Arguing against this hypothesis is
a study of 1700 newborn boys that found testis size was larger in
Finnish than Danish neonates, (Main et al, 2006), although
testicular cancer rates are much higher in Denmark
than in Finland (Chia et al, 2010). Another hypothesis is that
cryptorchidism may be associated with height, although Taskinen
Overall  (I2 = 76.5%, P = 0.000)
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Risk estimates and 95% confidence intervals (log scale)
Figure 1 Forest plot of the association between height (per 5cm) and testicular cancer risk. Each study-specific estimate is represented by a small solid
diamond with adjoining horizontal lines, which represent the 95% confidence intervals. The size of the grey square surrounding the
study-specific estimates represents the weight of each study in the meta-analysis. The diamond with an ascending dashed line from its upper point is
the summary estimate. The width of diamond represents the 95% confidence intervals of the summary estimate.
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Figure 2 Forest plot of the association between weight (per kg) and testicular cancer risk. Each study-specific estimate is represented by a small solid
diamond with adjoining horizontal lines which represent the 95% confidence intervals. The size of the grey square surrounding the
study-specific estimates represents the weight of each study in the meta-analysis. The diamond with an ascending dashed line from its upper point is
the summary estimate. The width of diamond represents the 95% confidence intervals of the summary estimate.
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addition, we find no evidence for such a relationship in our US
Servicemen’s Testicular Tumor Environmental and Endocrine
Determinants (STEED) case-control study (McGlynn et al, 2007;
unpublished data), which is also supported by the findings of a
previous study (Schnakenburg et al, 1977). Other studies aiming to
elucidate the association between height and TGCT have assessed
insulin-like growth factor and insulin-like growth factor-binding
proteins (Juul et al, 1994; Khandwala et al, 2000; Chia et al, 2008),
and early onset of puberty (Hagg and Taranger, 1992; Karlberg,
.
.
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Figure 3 Forest plot of the association between weight (per kg) and testicular cancer risk stratified by continent. Each study-specific estimate is
represented by a small solid diamond with adjoining horizontal lines which represent the 95% confidence intervals. The size of the grey square surrounding
the study-specific estimates represents the weight of each study in the meta-analysis. The diamond with an ascending dashed line from its upper point is the
summary estimate. The width of diamond represents the 95% confidence intervals of the summary estimate.
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Figure 4 Forest plot of the association between body mass index (per kgm
 2) and testicular cancer risk. Each study-specific estimate is represented by a
small solid diamond with adjoining horizontal lines which represent the 95% confidence intervals. The size of the grey square surrounding the study-specific
estimates represents the weight of each study in the meta-analysis. The diamond with an ascending dashed line from its upper point is the summary estimate.
The width of diamond represents the 95% confidence intervals of the summary estimate.
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hypothesis.
We found no evidence of an association between weight and
TGCT. The studies examined reported a slightly positive to slightly
negative associations, but none of the ORs attained statistical
significance. Four studies could not be included because data
were unavailable or authors could not be contacted (Lin
and Kessler, 1979; Whittemore et al, 1984; Davies et al, 1996;
Rasmussen et al, 2003). Weight adjusted for height, as in the BMI
metric, is likely to be a more sensitive marker of excess body fat
providing increased statistical power to detect any association with
TGCT.
The summary OR of both the continuous and categorical
analyses implied an inverse association of BMI with TGCT risk. Of
the four studies (Lin and Kessler, 1979; Kleinteich and Marx, 1983;
Thune and Lund, 1994; Rasmussen et al, 2003) not included in the
BMI analyses, two found a positive association between BMI and
TGCT (Lin and Kessler, 1979; Thune and Lund, 1994), one found a
trend toward an inverse association (Kleinteich and Mark, 1983),
and one found no association (Rasmussen et al, 2003). It is
possible that the inclusion of one or more of these studies in our
meta-analyses could have influenced the BMI meta-analyses. If the
two excluded studies reporting a positive association (Lin and
Kessler, 1979; Thune and Lund, 1994) had been included, the
overall effect estimate would have been weakened (Lin and Kessler,
1979; Thune and Lund, 1994). Of the studies that were included,
the study by Dieckmann et al (2009) was highly influential,
especially in the categorical analyses; when it was removed from
the overweight against normal weight categorical BMI analysis, the
summary estimate remained statistically significant and the
confidence interval tightened (OR¼0.87, 95% CI: 0.80, 0.95).
When the Dieckmann (2009) study was removed from the obese
against normal weight categorical BMI analysis, the summary
estimate did not reach statistical significance (OR¼0.85, 95% CI:
0.71, 1.01). However the heterogeneity (I
2) decreased significantly,
from 48% to 7%. This study did differ somewhat in terms of study
design when compared with the other studies included in the
categorical BMI meta-analyses. It was a large, multi-centre case-
control study in which cases were enroled both prospectively and
retrospectively during a specified period. Controls were taken from
the German National Health Survey; because TGCTs are more
prevalent in younger men, only men aged 18–49 years were
abstracted and chosen for these analyses. The authors could not
calculate relative risks because the exact BMI of control individuals
was not known; rather, BMI data was ascertained in categories of
exposure (Dieckmann et al, 2009). Despite the differences, there is
little reason to believe that they would contribute to a false-positive
finding. The large study size, including nearly 8500 cases, gives a
cause to believe that the findings in this study may be equally, if
not more, valid relative to other studies.
The current study had several notable strengths. The search
strategy was extremely thorough: we used a very broad search and
narrowed our findings by manually reviewing titles, abstracts, and
articles. In addition, we did not exclude studies based on language
or year of report, and we systematically contacted authors in
requests for additional information/data. Unadjusted estimates for
OR were included in these meta-analyses; thus all the statistical
models were equivalent. This may be a preferred strategy as
opposed to combining estimates adjusted for different sets of
variables. In addition, height does not vary greatly by age in
adulthood, so age as a potential confounder would only pertain to
the BMI and weight meta-analyses. We also checked for any
.
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Figure 5 Forest plot of the association between body mass index (categorical) and testicular cancer risk. Each study-specific estimate is represented by a
small solid diamond with adjoining horizontal lines which represent the 95% confidence intervals. The size of the grey square surrounding the study-specific
estimates represents the weight of each study in the meta-analysis. The diamond with an ascending dashed line from its upper point is the summary estimate.
The width of diamond represents the 95% confidence intervals of the summary estimate.
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Egger and Begg’s tests, as well as sensitivity analyses to assess the
impact of each individual study on summary estimates. In
addition, this is the first meta-analysis of the variables height
(continuous), weight (continuous), and BMI (continuous and
categorical) in relation to TGCT risk.
This analysis also has several limitations. It was not feasible to
include every identified study in the meta-analysis, because three
cohort studies (Whittemore et al, 1984; Thune and Lund, 1994;
Rasmussen et al, 2003) did not provide the necessary statistics for
their inclusion and the methods employed do not lend themselves
to estimation of hazard ratios. In addition, five case-control studies
had collected the relevant data but did not provide the appro-
priate ORs, and unfortunately this data could not be obtained
through correspondence (Lin and Kessler, 1979; Depue et al, 1983;
Kleinteich and Marx, 1983; Brown et al, 1987; Davies et al, 1996).
However, these eight studies were included in the discussion of the
results we present herein. A second limitation is that the estimates
used for the meta-analyses were unadjusted, and thus potential
confounding variables could not be taken into account. However,
as previously mentioned, by calculating the individual study
estimates using the same statistical method, we were able to
increase the validity of our meta-analytic approach. Also, there
is very little difference between unadjusted/minimally adjusted
and adjusted estimates in studies which have published such
(UKTCSG, 1994; Gallagher et al, 1995; Dieckmann and Pichlmeier,
2002; Richiardi et al, 2003; McGlynn et al, 2007). Furthermore,
given that the mechanism of the relationship of body size
and TGCT is not well understood, and that no variable has been
shown to consistently and significantly alter such, we believe the
most prudent approach is to combine unadjusted study-specific
estimates rather than pursue a strategy based on artificial adjust-
ment. A third limitation is that we could not identify the cause(s)
of heterogeneity detected in the meta-analysis of height and
TGCT even though we employed meta-regression using variables
specified a priori. The high levels of heterogeneity do not
invalidate the findings presented herein, but they do warrant
somewhat of a cautious interpretation. A fourth limitation is that
weight was not measured in a uniform manner throughout the
included studies. Rather, weight was measured at different points
before or at the time of diagnosis, as specified in the individual
study methods and summarised above. Weight can vary greatly
throughout a person’s life, and it may have more or less influence
at different points in the disease process. Thus, to ensure meta-
analytic validity and minimise heterogeneity, it is important that
weight is collected at similar points in the disease process for each
study included. The studies included here were limited to those in
which weight was measured at or before diagnosis; post-diagnostic
weight is more likely to be a reflection of treatment and stress
associated with disease. Differences in the timing and method of
weight measurement could have contributed to the heterogeneity
of the weight meta-analyses, although a sensitivity analysis of the
included studies demonstrated that no single study was dominant.
One final limitation is the lack of prospective studies available for
inclusion in this meta-analysis. There are very few cohort studies
looking at the relationship between body size and TGCTs, and only
one could be included in these meta-analyses (Bjorge et al, 2006).
Given the rarity of TGCT, cohort studies typically accrue few
cases, making this an inefficient study design when one considers
the balance of statistical power to financial costs. The findings
of Bjorge et al (2006) were comparable to the overall summary
estimates from our meta-analyses; there was a small positive
relationship between height and TGCTs, a small inverse relation-
ship between BMI and TGCTs, and no association between weight
and TGCTs.
This study provides support for a positive association between
height and TGCT, but little support for an association between
weight and TGCT. Further investigation of the inverse relationship
between BMI and TGCT may be warranted, for which the present
findings lend only limited support.
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